Drug Discovery World

JULY 19, 2024

Biotechnology company Draupnir Bio has received equity investments totalling €12 million to support the company’s work in the field of targeted protein degradation (TPD).

Targeted Protein Degradation 130

Targeted Protein Degradation Small Molecule Research Government 130

Drug Discovery World

DECEMBER 27, 2023

Dr Pierre Eftehkari, Chief Scientific Officer of Inoviem Scientific, joined the podcast series to share his insight into the future of drug development, leaning on his in-depth understanding of the pharmaceutical industry and its needs. A deep dive into US drug discovery What lies in the future for genomics and big data?

Targeted Protein Degradation 173

Targeted Protein Degradation Clinical Trials Pharma Companies Drug Development 173

Drug Discovery World

MARCH 22, 2023

It will combine the use of novel Huntington’s disease drug targets from Aitia’s Gemini Digital Twins with UCB’s expertise in drug research and preclinical model systems in neurodegeneration, with the aim to accelerate the discovery of new therapies for people living with Huntington’s disease.

Targeted Protein Degradation 130

Targeted Protein Degradation Drugs Small Molecule Licensing 130

Drug Discovery World

OCTOBER 6, 2022

With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. This growth is due to factors including a rise in speciality medicines, an increase in lifestyle-driven diseases and a growing population 1. Volume 23 – Issue 4, Fall 2022.

Targeted Protein Degradation 130

Targeted Protein Degradation Drugs Pharma Companies Marketing 130

Drug Discovery World

OCTOBER 16, 2023

A company within this ecosystem is STORM Therapeutics, a clinical stage biotechnology company creating novel small molecule therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. billion in funding. Northern Ireland “Northern Ireland is a medtech super-hub,” says Saleko.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Drug Discovery World

APRIL 6, 2023

These topics will be represented across a range of session types, including methods workshops, minisymposia, poster and plenary sessions, as well as keynotes, awards and lectures.

Small Molecule 130

Small Molecule Targeted Protein Degradation Clinical Trials Engineering 130

Drug Discovery World

MAY 11, 2023

However, she also presented thoughts in a technical update, Targeted Protein Degradation – Progress, Direction and Prospects. At previous events, there has been an air of excitement but uncertainty of how quickly to adopt ‘business as usual’. This uncertainty seems to be a thing of the past, if BioTrinity is anything to go by.

Targeted Protein Degradation 130

Targeted Protein Degradation Science Small Molecule Vaccine 130